Risky stem-cell therapy clinics popping up across US
Patients are mortgaging their homes to pay for the experimental treatments, a study reports
A worrying number of clinics that directly advertise expensive, unproven stem-cell therapies to patients with serious eye diseases, often with devastating results, are operating across the US, a new study warns.
Although there are no approved stem-cell therapies to treat eye conditions in the US, when the authors of the study conducted a systematic web search, they found 40 companies with 76 clinics that advertised the procedures.
